The United States has recently purchased 13 million doses of the monkeypox vaccine after a case that was reported in Massachusetts.

RELATED STORIES: First Monkeypox Case Reported In The United States For This Year
The Jynneos vaccine doses were purchased for $113 million from the biotechnology company Bavarian Nordic and the shot can be used to treat both monkeypox and smallpox as reported by the New York Post. Since 2003, the United States has used the vaccine as a treatment against the disease. As previously reported, a Massachusetts man contracted the disease after a trip to Canada but hospital officials said he doesn’t pose a risk to the public.
“The case poses no risk to the public, and the individual is hospitalized and in good condition. DPH is working closely with the CDC, relevant local boards of health, and the patient’s health care providers to identify individuals who may have been in contact with the patient while he was infectious.”
Doing what? The smallpox vaccine more or less covers monkey pox. It’s a vaccine that’s been around for decades and many people already have that or the chickenpox vaccine. Chickenpox vaccine is standard for kids these days.
— J. Jonah Jameson (@JJJamesonBugle) May 20, 2022
RELATED STORIES: Texas Man Quarantined After Contracting Monkeypox, First Case In The U.S. Since 2003
Recently, there were several cases of the disease in the United Kingdom and two cases were reported in the United States in 2021. Symptoms of the disease include headache, fever, body aches, swollen lymph nodes, rashes, and chills. The Jynneos vaccine is the only monkeypox shot that has been approved by the Food and Drug Administration. Most of the patients from the cases in the UK are mostly men.
learned about monkey pox today
could we just not
just not have another ghastly pandemic
as a treat
— Josh Cincinnati (@acityinohio) May 20, 2022
The outlet also reported that there could be a possible monkeypox case in New York City. Officials from the Department of Health and Mental Hygiene said tests will be conducted to see if the samples are positive for monkeypox. Currently, the patient is in isolation and will follow all protocols based on procedures at Bellevue Hospital.
MONKEYPOX??? pic.twitter.com/TZrlCGyHvh
— Natalia Lopez (@Taliana83) May 20, 2022
Due to the news of monkeypox, social media users were upset due to the reminder that the world is still battling the coronavirus pandemic and some even opposed the monkeypox vaccine.
I know it’s early but, I’m not taking a monkey pox vaccine either.
— Scotty 🇨🇦 (@RightOfEast) May 19, 2022
US and Britain already ramping up their monkeypox vaccine orders – I hope we’re doing the same…
— Dr Kate Miller (@DrKate_Miller) May 19, 2022
I was born after they stopped vaccinating for smallpox and don’t have the telltale scar. I’m not looking for a smallpox vaccine.
Why?
I’m much more likely to get COVID, so I’m vaccinated for that and continuing to take precautions (which also reduce monkeypox exposure risk).
— Dr. Angela Rasmussen (@angie_rasmussen) May 20, 2022
However, there is a non-replicating vaccine for smallpox (and monkeypox) called JYNNEOS, which is safe in immunocompromised people and persons with skin diseases
— John Ross 💉💉💉 (@JohnRossMD) May 18, 2022